Nε-(carboxymethyl)lysine promotes lipid uptake of macrophage via cluster of differentiation 36 and receptor for advanced glycation end products

doi:10.4239/wjd.v14.i3.222

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3547)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

187

WORD

HTML

1726

Figures (1-5)

313

Sum=2257

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

158

Download

525

Sum=683

Publishing Process of This Article

Item

Count

Browse

142

Download

465

Sum=607

Mar 15, 2023 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Mar 15, 2023; 14(3): 222-233
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.222

Full Size Figure Download Figure

Figure 5 N^ε-(carboxymethyl)lysine promotes lipid uptake by macrophages through receptor for advanced glycation end products and cluster of differentiation 36. CD36: Cluster of differentiation 36; RAGE: Receptor for advanced glycation end products; CML: N^ε-(carboxymethyl)lysine.

Citation: Wang ZQ, Yao HP, Sun Z. N^ε-(carboxymethyl)lysine promotes lipid uptake of macrophage via cluster of differentiation 36 and receptor for advanced glycation end products. World J Diabetes 2023; 14(3): 222-233
URL: https://www.wjgnet.com/1948-9358/full/v14/i3/222.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i3.222